(SPARC) Sun Pharma Advanced Research Company Limited conducts pharmaceutical product research and development (R&D).
Financial Results:
After nine consecutive quarters of losses, Sun Pharma Advanced Research Company declared a net profit of Rs. 10.15 crore for the months of October through December, turning a profit once more. Over the same time a year prior, the firm posted a net loss of ₹ 15.8 crore.
In comparison to the same quarter a year prior, the company’s operating revenue more than quadrupled to Rs 131.1 crore.